BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 16490701)

  • 1. Tuberculosis in cattle: how to get the upper hand.
    Karls R
    Vet J; 2006 Mar; 171(2):193-4. PubMed ID: 16490701
    [No Abstract]   [Full Text] [Related]  

  • 2. Progress in the development of vaccines and diagnostic reagents to control tuberculosis in cattle.
    Vordermeier HM; Chambers MA; Buddle BM; Pollock JM; Hewinson RG
    Vet J; 2006 Mar; 171(2):229-44. PubMed ID: 16490705
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mycobacterium bovis DeltaleuD auxotroph-induced protective immunity against tissue colonization, burden and distribution in cattle intranasally challenged with Mycobacterium bovis Ravenel S.
    Khare S; Hondalus MK; Nunes J; Bloom BR; Garry Adams L
    Vaccine; 2007 Feb; 25(10):1743-55. PubMed ID: 17240005
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tuberculosis vaccines for cattle: the way forward.
    Buddle BM
    Expert Rev Vaccines; 2010 Oct; 9(10):1121-4. PubMed ID: 20923262
    [No Abstract]   [Full Text] [Related]  

  • 5. Tackling the problem of tuberculosis in cattle and people.
    Vet Rec; 2003 May; 152(20):608-10. PubMed ID: 12790163
    [No Abstract]   [Full Text] [Related]  

  • 6. Immunogenicity of Mycobacterium tuberculosis antigens in Mycobacterium bovis BCG-vaccinated and M. bovis-infected cattle.
    Mustafa AS; Skeiky YA; Al-Attiyah R; Alderson MR; Hewinson RG; Vordermeier HM
    Infect Immun; 2006 Aug; 74(8):4566-72. PubMed ID: 16861643
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Significance of paraallergy in the diagnosis of tuberculosis in animals].
    Iudin GA
    Veterinariia; 1972 Sep; 9():95-8. PubMed ID: 4582353
    [No Abstract]   [Full Text] [Related]  

  • 8. Is interleukin-4delta3 splice variant expression in bovine tuberculosis a marker of protective immunity?
    Rhodes SG; Sawyer J; Whelan AO; Dean GS; Coad M; Ewer KJ; Waldvogel AS; Zakher A; Clifford DJ; Hewinson RG; Vordermeier HM
    Infect Immun; 2007 Jun; 75(6):3006-13. PubMed ID: 17387165
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bovine TB and the development of new vaccines.
    Hope JC; Villarreal-Ramos B
    Comp Immunol Microbiol Infect Dis; 2008 Mar; 31(2-3):77-100. PubMed ID: 17764740
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immunotherapy with combined DNA vaccines is an effective treatment for M. bovis infection in cattle.
    Hu XD; Chen ST; Yu DH; Li SX; Cai H
    Vaccine; 2009 Feb; 27(9):1317-22. PubMed ID: 19162110
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Potential challenges to the Stop TB Plan for humans in China; cattle maintain M. bovis and M. tuberculosis.
    Chen Y; Chao Y; Deng Q; Liu T; Xiang J; Chen J; Zhou J; Zhan Z; Kuang Y; Cai H; Chen H; Guo A
    Tuberculosis (Edinb); 2009 Jan; 89(1):95-100. PubMed ID: 19056318
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pathogenesis of Mycobacterium bovis infection.
    Thoen CO; Himes EM
    Prog Vet Microbiol Immunol; 1986; 2():198-214. PubMed ID: 3078650
    [No Abstract]   [Full Text] [Related]  

  • 13. [Tuberculosis in cattle].
    Emmerzaal A
    Tijdschr Diergeneeskd; 1993 Mar; 118(6):202-3. PubMed ID: 8465352
    [No Abstract]   [Full Text] [Related]  

  • 14. [Histomorphological changes of tubercular granuloma in relation to the experimental pathogenic activity of various strains of Mycobacterium tuberculosis of the bovis type].
    Mammini P; Marchesini A
    Arch De Vecchi Anat Patol; 1968 Jul; 51(3):943-61. PubMed ID: 4902480
    [No Abstract]   [Full Text] [Related]  

  • 15. Experimental exposure of cattle to a precise aerosolised challenge of Mycobacterium bovis: a novel model to study bovine tuberculosis.
    Rodgers JD; Connery NL; McNair J; Welsh MD; Skuce RA; Bryson DG; McMurray DN; Pollock JM
    Tuberculosis (Edinb); 2007 Sep; 87(5):405-14. PubMed ID: 17602870
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immunohistochemical markers augment evaluation of vaccine efficacy and disease severity in bacillus Calmette-Guerin (BCG) vaccinated cattle challenged with Mycobacterium bovis.
    Johnson L; Gough J; Spencer Y; Hewinson G; Vordermeier M; Wangoo A
    Vet Immunol Immunopathol; 2006 Jun; 111(3-4):219-29. PubMed ID: 16540176
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Consequence of prior exposure to environmental mycobacteria on BCG vaccination and diagnosis of tuberculosis infection.
    Thom M; Howard C; Villarreal-Ramos B; Mead E; Vordermeier M; Hope J
    Tuberculosis (Edinb); 2008 Jul; 88(4):324-34. PubMed ID: 18329343
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Reaction to tuberculin in cows and immune response to tuberculosis pathogen antigens in cattle-breeders].
    Iakovleva LF; Lysenko AP; Lemish AP; Arkhipov EL; Pritychenko AN; Rubnikovich TP; Vlasenko IG
    Probl Tuberk Bolezn Legk; 2008; (3):20-3. PubMed ID: 18453054
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Study of the immunological profile towards Mycobacterium bovis antigens in naturally infected cattle.
    Blanco FC; Schierloh P; Bianco MV; Caimi K; Meikle V; Alito AE; Cataldi AA; Sasiain Mdel C; Bigi F
    Microbiol Immunol; 2009 Aug; 53(8):460-7. PubMed ID: 19659930
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Survival rate of airborne Mycobacterium bovis.
    Gannon BW; Hayes CM; Roe JM
    Res Vet Sci; 2007 Apr; 82(2):169-72. PubMed ID: 17045316
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.